INFLUENCE OF PREECLAMPSIA INTO PHYSIOLOGICAL AND PATHOLOGICAL PROCESSES IN THE VESSELS AND THE RISK OF HEART DISEASE AFTER BIRTH
https://doi.org/10.18705/2311-4495-2014-0-4-46-50
Abstract
This review summarizes current understanding of the function of blood vessels, valuation methodologies the vascular wall, the adaptive changes that occur in it during normal pregnancy.
About the Authors
Nikita R. Ryabokon
Federal Almazov Medical Research Centre
Russian Federation
Russian Federation
L. V. Kuznetsova
Federal Almazov Medical Research Centre
Russian Federation
Russian Federation
I. E. Zazerskaya
Federal Almazov Medical Research Centre
Russian Federation
Russian Federation
References
1. Mayhew T.M. Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodeling of vascular endothelial cells // Placenta. - 2002. - Vol. 23. - P. 742-750.
2. Jaffe R., Jauniaux E., Hustin J. Maternal circulation in the first-trimester human placenta - myth or reality? // Am. J. Obstet. Gynecol. - 1997. - Vol. 176, № 3. - P. 699-705.
3. Risau W., Flamme I. Vasculogenesis // Ann. Rev. Cell. Dev. Biol. - 2005. - Vol. 11. - P. 73-91.
4. Charnock-Jones D.S., Kaufmann P., Mayhew T.M. Aspects of human fetoplacental vasculogenesis and angiogenesis I. Molecular regulation // Placenta. - 2004. - Vol. 25, № 2-3. - P. 103-113.
5. Никитина Л.А., Демидова Е.И., Радзинский В.Е. и др. Роль матриксных белков, цитокинов и факторов ангиогенеза маточно-плацентарного комплекса в регуляции имплантации и плацентации // Акушерство и гинекология. - 2007. - Т. 3. - С. 5-10.
6. Yancopoulos G.D., Davis S., Gale N.W. et al. Vascular-specific growth factors and blood vessel formation // Nature. - 2000. - Vol. 407, № 6801. - P. 242-248.
7. Smith S.K. Angiogenesis and reproduction // Br. J. Obstetr. and Gyn. - 2001. - Vol. 108. - P. 777-783.
8. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress // Endocrin. Rev. - 2004. - Vol. 25. - P. 581-611.
9. Naldini A., Carraro F. Role of inflammatory mediators in angiogenesis // Curr. Drug Targets Inflamm. Allergy. - 2005. - Vol. 4. - P. 3-18.
10. Hanna J., Goldman-Wohl D., Hamani Y. et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. - Nat. Med. - 2006. - Vol. 12. - P. 1065-1074.
11. Hayashi T., Matsuoka K., Saitoh M. et al. Influence of alpha-tumor necrosis factor and beta-interleukin-1 on production of angiogenetic factors and thymidine phosphorylase activity in immortalized human decidual fibroblasts in vitro // J. Obstet. Gynaecol. - 2006. - Vol. 32. - P. 15-22.
12. Beck Jr. L., D’Amore P.A. Vascular development: cellular and molecular regulation. - FASEB. J. - 2011. - Vol. 11. - P. 365-373.
13. Ortega N., L’Faqihi F.E., Plouet J. Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix // Biol Cell. - 1998. - Vol. 90. - P. 381-390.
14. Breier G., Damert A., Plate K.H., Risau W. Angiogenesis in embryos and ischemic diseases // Thromb. Haemost. - 2007. - Vol. 78. - P. 678-683.
15. Shalaby F., Rossant J., Yamaguchi T.P. et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice // Nature. - 1995. - Vol. 376. - P. 62-66.
16. Zhou Y., Fisher S.J., Janatpour M. et al. Human cytot-rophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion? // J. Clin. Invest. - 2007. - Vol. 99. - P. 2139-2151.
17. Roberts J.M. Endothelial dysfunction in preeclampsia // Sem. Reprod. Endocrinol. - 2008. - Vol.16. - P. 5-15.
18. Johnston R.W. Toxaemias of pregnancy. A Textbook of Midwifery. - London: A&C Black, 1989. - P. 237-259.
19. Baker P.N., Krasnow J., Roberts J.M. et al. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia // Obstet. Gynecol. - 2005. - Vol. 86. - P. 815-821.
20. Sharkey A.M., Cooper J.C., Balmforth J.R. et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies-complicated by pre-eclampsia // Europ. J. Clin. Investig. - 2006. - Vol. 26. - P. 1182-1185.
21. Brockelsby J., Hayman R., Ahmed A. et al. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia // Lab. Invest. - 2009. - Vol. 79. - P. 1101-1111.
22. Torry D.S., Wang H.S., Wang T.H., et al. Preeclampsia is associated with reduced serum levels of placenta growth factor // Am. J. Obstet. Gynecol. - 2009. - Vol. 179. - P. 1539-1544.
23. Duckitt K., Harrington D. Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. - BMJ. - 2005. - Vol. 330. - P. 565.
24. Cnattingius S., Reilly M., Pawitan Y., et al. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study // Am. J. Med. Genet. - 2004. - Vol. 130A. - P. 365-371.
25. Nilsson E., Salonen R.H., Cnattingius S. et al. The importance of genetic and environmental effects for preeclampsia and gestational hypertension: a family study. - BJOG. - 2004. - Vol. 111. - P. 200-206.
26. Haukkamaa L., Moilanen L., Kattainen A. et al. Pre-eclampsia is a risk factor of carotid artery atherosclerosis // Cerebrovasc. Dis. - 2009. - Vol. 27. - P. 599-607.
27. Versen-Hoeynck F.M., Hubel C.A., Gallaher M.J. et al. Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia // Am. J. Hypertens. - 2009. - Vol. 22. - P. 687-692.
28. Jantos-Siwy J., Schiffer E., Brand K. et al. Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease // J. Proteome Res. - 2009. - Vol. 8. - P. 268-281.
29. Verlohren S., Galindo A., Schlembach D. et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia // Am. J. Obstet. Gynecol. - 2010. - Vol. 202. - P. 161.
30. Mitchell G.F. et al. Arterial swiftness and cardiovascular events, the Framingham Heart Study. Circulation - 2010. - Vol. 121, № 4. - P. 505-11 2010
31. O’Rourke M.F., et. al. The pulse of cardiologyl // Journal of American college of cardiology - 2009. - Vol. 54. - P. 714-717
32. Кобалава Ж.Д., и др. Проблемы взаимодействия врача и пациента и контроль артериальной гипертонии в России // Кардиология - 2007. - Vol. 3. - С. 38-47.
Review
For citations:
Ryabokon N.R., Kuznetsova L.V., Zazerskaya I.E. INFLUENCE OF PREECLAMPSIA INTO PHYSIOLOGICAL AND PATHOLOGICAL PROCESSES IN THE VESSELS AND THE RISK OF HEART DISEASE AFTER BIRTH. Translational Medicine. 2014;(4):46-50. (In Russ.) https://doi.org/10.18705/2311-4495-2014-0-4-46-50
Views:
796
Email this article 